federal_register: 2017-11862
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-11862 | Bacteriophage Therapy: Scientific and Regulatory Issues; Public Workshop | Notice | The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled "Bacteriophage Therapy: Scientific and Regulatory Issues." The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy. | 2017-06-08 | 2017 | 6 | https://www.federalregister.gov/documents/2017/06/08/2017-11862/bacteriophage-therapy-scientific-and-regulatory-issues-public-workshop | https://www.govinfo.gov/content/pkg/FR-2017-06-08/pdf/2017-11862.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled "Bacteriophage Therapy:... |